Analysts at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report released on Tuesday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens boosted their price target on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, January 31st.
Read Our Latest Analysis on MDRX
Veradigm Trading Up 1.6 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- Using the MarketBeat Stock Split Calculator
- Energy Transfer: Powering Data With Dividends and Diversification
- The Risks of Owning Bonds
- Qualcomm Stock Is Coiling for a Breakout
- How to Short Nasdaq: An Easy-to-Follow Guide
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
